CD8A and cancer: Interestingly, in cancers that show resistance to PD1 inhibitor, CD38 expression is upregulated in exhausted CD8 T cell populations[167,168], but a critical role of CD38-mediated NAD+ depletion in resistance to PD1 inhibitor cancer therapy needs further investigation.